The role of IL-13 and NK T cells in experimental and human ulcerative colitis
Open Access
- 15 October 2008
- journal article
- review article
- Published by Elsevier in Mucosal Immunology
- Vol. 1 (1), S31-S33
- https://doi.org/10.1038/mi.2008.40
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosisNature Medicine, 2005
- Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell RestitutionGastroenterology, 2005
- CD1: Antigen Presentation and T Cell FunctionAnnual Review of Immunology, 2004
- Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cellsGastroenterology, 2003
- Oxazolone Colitis, a Th2 Colitis Model Resembling Ulcerative Colitis, Is Mediated by IL-13-Producing NK-T CellsImmunity, 2002
- The unconventional lifestyle of NKT cellsNature Reviews Immunology, 2002
- Activation of a Nonclassical NKT Cell Subset in a Transgenic Mouse Model of Hepatitis B Virus InfectionImmunity, 2002
- Oxazolone Colitis: A Murine Model of T Helper Cell Type 2 Colitis Treatable with Antibodies to Interleukin 4The Journal of Experimental Medicine, 1998
- IL-18 Augments Perforin-Dependent Cytotoxicity of Liver NK-T CellsThe Journal of Immunology, 1998
- TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1.The Journal of Experimental Medicine, 1995